How do you pay?

How to pay the least

Ask for the cash price

Voquezna Dual Pak

No generic is sold yet.

  1. Ask your pharmacy for Voquezna Dual Pak’s cash price, and one or two other pharmacies too.
  2. Voquezna Dual Pak’s savings card works only with insurance from a job or one you bought.

Compare every option

Question
Brand nameVoquezna Dual Pak
Authorized genericvonoprazan and amoxicillin
Regular genericvonoprazan and amoxicillin
What you’d pay
Cash priceAsk the pharmacy
Not soldThere isn’t one
Not soldNone sold yet
Same as the brand?
The original
–
–

Brand nameThe maker’s card

VOQUEZNA Dual Pak Savings Card

Savings card from Phathom Pharmaceuticals

No insuranceNeeds insuranceNo cash price listed.
Insurance · as little as $25 a fill

The card takes up to $316 a fill off your co-pay.

Sign up on voquezna.com 

In the maker’s words

“Patient must have commercial drug insurance with insurance provider coverage for VOQUEZNA Triple Pak or VOQUEZNA Dual Pak to pay as little as $25.”

From the maker’s offer on voquezna.com, checked November 2, 2026. Co-pay cards can’t be used with Medicare (including Medicare Advantage), Medicaid, TRICARE or VA.

Maker’s card or discount card?

A discount card like GoodRx lowers the pharmacy’s cash price, but for a brand-name drug that price often stays high. Compare it with the maker’s card above. You can usually use one or the other on a fill, not both.

Authorized genericNot sold

There isn’t one. An authorized generic is Voquezna Dual Pak itself, from the same company, sold without the brand name, and usually for less. For now Voquezna Dual Pak is the only choice; its maker’s savings card can lower what you pay.

See the brand name →

Regular genericNot sold

No generic is sold yet. Generics usually come once the brand’s patents and exclusivity end. Until then, the maker’s savings card is the way to pay less.

See the brand name →

What it’s used for

What the FDA label says

VOQUEZNA TRIPLE PAK, is a co-packaged product containing vonoprazan, a potassium-competitive acid blocker (PCAB), amoxicillin, a penicillin class antibacterial, and clarithromycin, a macrolide antimicrobial, indicated for the treatment of Helicobacter pylori (H. pylori) infection in adults.

VOQUEZNA DUAL PAK, is a co-packaged product containing vonoprazan, a PCAB, and amoxicillin, a penicillin class antibacterial, indicated for the treatment of H. pylori infection in adults.

To reduce the development of drug-resistant bacteria and maintain the effectiveness of VOQUEZNA TRIPLE PAK, VOQUEZNA DUAL PAK and other antibacterial drugs, VOQUEZNA TRIPLE PAK and VOQUEZNA DUAL PAK should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria.

Source: the FDA label for Voquezna Dual Pak (Phathom Pharmaceuticals Inc.), July 16, 2026. Full label on DailyMed 

Good to know